---
schema_version: "secwatch.filing_event.v1"
accession: "0001618835-21-000245"
form_type: "8-K"
ticker: "EVFM"
cik: "0001618835"
company_name: "Evofem Biosciences, Inc."
filed_at: "2021-11-19T23:59:59+00:00"
generated_at: "2026-06-28T06:34:17.306963+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Director William Hall resigns from Evofem board due to health concerns

## Summary
- Dr. William Hall resigned effective Nov. 17, 2021, citing health issues.
- Resignation was not due to any disagreement with the Company or Board.
- Company has engaged a search firm to find a new Board Chairperson.

## SEC filing metadata
- accession: 0001618835-21-000245
- form_type: 8-K
- ticker: EVFM
- cik: 0001618835
- company_name: Evofem Biosciences, Inc.
- filed_at: 2021-11-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1618835/000161883521000245/0001618835-21-000245-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1618835/000161883521000245/evfm-20211117.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001618835-21-000245
- JSON: https://secwatch.observer/filing/0001618835-21-000245.json
- Plain text: https://secwatch.observer/filing/0001618835-21-000245.txt

## Key facts
- Executive change
  William Hall resigned as member of the Board at Evofem Biosciences, Inc..
  - Action: resigned
  - Role: member of the Board
  source text: On November 17, 2021, William Hall, Ph.D., M.D. notified the Board of Directors (the "Board") of Evofem Biosciences, Inc., a Delaware corporation (the "Company"), of his intention to resign as a member of the Board effective immediately due to health concerns.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1618835/000161883521000245/0001618835-21-000245-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.